
An eye-popping study—published in the October 2013 issue of Health Affairs by top scientists at USC, Harvard, Columbia, the University of Illinois at Chicago, and other institutions—found that investing in delaying aging would have a much greater impact on life expectancy than investing in diseases of aging directly.1
Continue reading “Slowing Biological Aging Vs. Curing All Diseases: A Truly Remarkable Study”


